Immunogenic properties of chemotherapeutic agents in the treatment of non-small cell lung cancer

被引:0
|
作者
Flieswasser, Tal [1 ]
Van Loenhout, Jinthe [1 ]
Boullosa, Laurie Freire [1 ]
Van den Eynde, Astrid [1 ]
De Waele, Jorrit [1 ]
Van Audenaerde, Jonas [1 ]
Lardon, Filip [1 ]
Smits, Evelien [1 ]
Pauwels, Patrick [2 ]
Julie, Jacobs [1 ]
机构
[1] Univ Antwerp, Antwerp, Belgium
[2] Antwerp Univ Hosp, Antwerp, Belgium
关键词
D O I
10.1158/1538-7445.AM2020-2414
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2414
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Effectiveness of immunological agents in non-small cell lung cancer
    Rekulapelli, Akhil
    Flausino, Lucas E.
    Iyer, Gayatri
    Balkrishnan, Rajesh
    CANCER REPORTS, 2023, 6 (01)
  • [32] Angiogenesis and antiangiogenic agents in non-small cell lung cancer
    Galligioni, E
    Ferro, A
    LUNG CANCER, 2001, 34 : S3 - S7
  • [33] Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents against non-small cell lung cancer (NSCLC)
    Sei, S.
    Yang, Q.
    Mussio, J.
    Coffey, M.
    Parchment, R.
    Shoemaker, R.
    Tomaszewski, J.
    EJC SUPPLEMENTS, 2006, 4 (12): : 103 - 103
  • [34] Novel cytotoxic agents for non-small cell lung cancer
    Edelman, Martin J.
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (07) : 752 - 755
  • [35] Investigational Agents in the Management of Non-Small Cell Lung Cancer
    Pennell, Nathan A.
    Mekhail, Tarek
    CURRENT ONCOLOGY REPORTS, 2009, 11 (04) : 275 - 284
  • [36] NEW AGENTS IN NON-SMALL CELL LUNG-CANCER
    JOSS, RA
    CAVALLI, F
    GOLDHIRSCH, A
    MERMILLOD, B
    BRUNNER, KW
    CANCER TREATMENT REVIEWS, 1984, 11 (03) : 205 - 236
  • [37] Integration of new chemotherapeutic agents into chemoradiotherapy for stage III non-small cell lung cancer: Focus on docetaxel
    Gandara, DR
    Lara, PN
    Goldberg, Z
    Lau, DHM
    SEMINARS IN ONCOLOGY, 2001, 28 (03) : 26 - 32
  • [38] Homology modelling and molecular docking of MDR1 with chemotherapeutic agents in non-small cell lung cancer
    Subhani, Syed
    Jayaraman, Archana
    Jamil, Kaiser
    BIOMEDICINE & PHARMACOTHERAPY, 2015, 71 : 37 - 45
  • [39] Chemotherapeutic agents and the EGFR-TKI osimertinib provoke calreticulin exposure in non-small cell lung cancer
    Inoue, Hiroyuki
    Furukawa, Rie
    Yoneshima, Yasuto
    Tsutsumi, Hirono
    Iwama, Eiji
    Ikematsu, Yuki
    Ando, Nobuhisa
    Shiraishi, Yoshimasa
    Ota, Keiichi
    Tanaka, Kentaro
    Okamoto, Isamu
    RESPIROLOGY, 2023, 28 : 305 - 305
  • [40] Single agents in the second-line treatment of non-small cell lung cancer
    Belani, CP
    SEMINARS IN ONCOLOGY, 1998, 25 (03) : 10 - 14